US Skin Graft Market

ID: MRFR/MED/17978-HCR
100 Pages
Nidhi Mandole
Last Updated: May 05, 2026
US Skin Graft Market Research Report By Type (Isogeneic, Autologous, Allogeneic, Xenogeneic, Prosthetic), By Thickness (Split-Thickness, Full-Thickness, Composite Graft), By Application (Extensive Wound, Burns, Extensive Skin Loss Due To Infection, Skin Cancers, Others), By Equipment (Dermatome, Knives Dermatomes, Drum Dermatomes, Electric Dermatomes, Air Dermatomes, General Surgical Instruments, Consumables, Others) and By End User (Hospitals And Clinics, Academic And Research, Others) - Growth & Industry Forecast 2025 To 2035
US Skin Graft Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)7.43%
2024 Market Size$ 500 Million
2025 Market Size$ 537.15 Million
2035 Market Size$ 1,100 Million
Key Players
Integra LifeSciences
MediWound Ltd.
Smith & Nephew
Organogenesis Holdings Inc.
Acelity L.P. Inc.
Sientra Inc.
Trends
  • Advancements in Graft Materials
  • Rising Incidence of Chronic Wounds
  • Focus on Personalized Medicine
Opportunities
  • Increasing Demand for Burn Treatment
  • Rising Awareness of Advanced Wound Care
  • Technological Innovations in Skin Grafting
Summary Table of Contents Segmentation Download PDF
  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
    1. 1.1 EXECUTIVE SUMMARY | |
      1. 1.1.1 Market Overview | |
      2. 1.1.2 Key Findings | |
      3. 1.1.3 Market Segmentation | |
      4. 1.1.4 Competitive Landscape | |
      5. 1.1.5 Challenges and Opportunities | |
      6. 1.1.6 Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
    1. 2.1 MARKET INTRODUCTION | |
      1. 2.1.1 Definition | |
      2. 2.1.2 Scope of the study | | |
        1. 2.1.2.1 Research Objective | | |
        2. 2.1.2.2 Assumption | | |
        3. 2.1.2.3 Limitations |
    2. 2.2 RESEARCH METHODOLOGY | |
      1. 2.2.1 Overview | |
      2. 2.2.2 Data Mining | |
      3. 2.2.3 Secondary Research | |
      4. 2.2.4 Primary Research | | |
        1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
        2. 2.2.4.2 Breakdown of Primary Respondents | |
      5. 2.2.5 Forecasting Model | |
      6. 2.2.6 Market Size Estimation | | |
        1. 2.2.6.1 Bottom-Up Approach | | |
        2. 2.2.6.2 Top-Down Approach | |
      7. 2.2.7 Data Triangulation | |
      8. 2.2.8 Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS |
    1. 3.1 MARKET DYNAMICS | |
      1. 3.1.1 Overview | |
      2. 3.1.2 Drivers | |
      3. 3.1.3 Restraints | |
      4. 3.1.4 Opportunities |
    2. 3.2 MARKET FACTOR ANALYSIS | |
      1. 3.2.1 Value chain Analysis | |
      2. 3.2.2 Porter's Five Forces Analysis | | |
        1. 3.2.2.1 Bargaining Power of Suppliers | | |
        2. 3.2.2.2 Bargaining Power of Buyers | | |
        3. 3.2.2.3 Threat of New Entrants | | |
        4. 3.2.2.4 Threat of Substitutes | | |
        5. 3.2.2.5 Intensity of Rivalry | |
      3. 3.2.3 COVID-19 Impact Analysis | | |
        1. 3.2.3.1 Market Impact Analysis | | |
        2. 3.2.3.2 Regional Impact | | |
        3. 3.2.3.3 Opportunity and Threat Analysis 4
  4. SECTION IV: QUANTITATIVE ANALYSIS |
    1. 4.1 Medical Device, BY Graft Type (USD Million) | |
      1. 4.1.1 Autograft | |
      2. 4.1.2 Allograft | |
      3. 4.1.3 Xenograft |
    2. 4.2 Medical Device, BY Product Type (USD Million) | |
      1. 4.2.1 Dermatome | |
      2. 4.2.2 Powered Dermatome | |
      3. 4.2.3 Drum and Knife Dermatome | |
      4. 4.2.4 Wound Debridement Devices | |
      5. 4.2.5 Others |
    3. 4.3 Medical Device, BY Application (USD Million) | |
      1. 4.3.1 Pressure & Venous Ulcers | |
      2. 4.3.2 Diabetic Foot Ulcers | |
      3. 4.3.3 Burns | |
      4. 4.3.4 Surgical Wounds | |
      5. 4.3.5 Others |
    4. 4.4 Medical Device, BY End User (USD Million) | |
      1. 4.4.1 Hospitals | |
      2. 4.4.2 Ambulatory Surgery Centers | |
      3. 4.4.3 Specialty Centers 5
  5. SECTION V: COMPETITIVE ANALYSIS |
    1. 5.1 Competitive Landscape | |
      1. 5.1.1 Overview | |
      2. 5.1.2 Competitive Analysis | |
      3. 5.1.3 Market share Analysis | |
      4. 5.1.4 Major Growth Strategy in the Medical Device | |
      5. 5.1.5 Competitive Benchmarking | |
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Medical Device | |
      7. 5.1.7 Key developments and growth strategies | | |
        1. 5.1.7.1 New Product Launch/Service Deployment | | |
        2. 5.1.7.2 Merger & Acquisitions | | |
        3. 5.1.7.3 Joint Ventures | |
      8. 5.1.8 Major Players Financial Matrix | | |
        1. 5.1.8.1 Sales and Operating Income | | |
        2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
    2. 5.2 Company Profiles | |
      1. 5.2.1 Integra LifeSciences (US) | | |
        1. 5.2.1.1 Financial Overview | | |
        2. 5.2.1.2 Products Offered | | |
        3. 5.2.1.3 Key Developments | | |
        4. 5.2.1.4 SWOT Analysis | | |
        5. 5.2.1.5 Key Strategies | |
      2. 5.2.2 MediWound Ltd. (IL) | | |
        1. 5.2.2.1 Financial Overview | | |
        2. 5.2.2.2 Products Offered | | |
        3. 5.2.2.3 Key Developments | | |
        4. 5.2.2.4 SWOT Analysis | | |
        5. 5.2.2.5 Key Strategies | |
      3. 5.2.3 Smith & Nephew (GB) | | |
        1. 5.2.3.1 Financial Overview | | |
        2. 5.2.3.2 Products Offered | | |
        3. 5.2.3.3 Key Developments | | |
        4. 5.2.3.4 SWOT Analysis | | |
        5. 5.2.3.5 Key Strategies | |
      4. 5.2.4 Organogenesis Holdings Inc. (US) | | |
        1. 5.2.4.1 Financial Overview | | |
        2. 5.2.4.2 Products Offered | | |
        3. 5.2.4.3 Key Developments | | |
        4. 5.2.4.4 SWOT Analysis | | |
        5. 5.2.4.5 Key Strategies | |
      5. 5.2.5 Acelity L.P. Inc. (US) | | |
        1. 5.2.5.1 Financial Overview | | |
        2. 5.2.5.2 Products Offered | | |
        3. 5.2.5.3 Key Developments | | |
        4. 5.2.5.4 SWOT Analysis | | |
        5. 5.2.5.5 Key Strategies | |
      6. 5.2.6 Sientra Inc. (US) | | |
        1. 5.2.6.1 Financial Overview | | |
        2. 5.2.6.2 Products Offered | | |
        3. 5.2.6.3 Key Developments | | |
        4. 5.2.6.4 SWOT Analysis | | |
        5. 5.2.6.5 Key Strategies | |
      7. 5.2.7 Medi-Globe Technologies (DE) | | |
        1. 5.2.7.1 Financial Overview | | |
        2. 5.2.7.2 Products Offered | | |
        3. 5.2.7.3 Key Developments | | |
        4. 5.2.7.4 SWOT Analysis | | |
        5. 5.2.7.5 Key Strategies | |
      8. 5.2.8 KCI Medical (US) | | |
        1. 5.2.8.1 Financial Overview | | |
        2. 5.2.8.2 Products Offered | | |
        3. 5.2.8.3 Key Developments | | |
        4. 5.2.8.4 SWOT Analysis | | |
        5. 5.2.8.5 Key Strategies |
    3. 5.3 Appendix | |
      1. 5.3.1 References | |
      2. 5.3.2 Related Reports 6 LIST OF FIGURES |
    4. 6.1 MARKET SYNOPSIS |
    5. 6.2 US MARKET ANALYSIS BY GRAFT TYPE |
    6. 6.3 US MARKET ANALYSIS BY PRODUCT TYPE |
    7. 6.4 US MARKET ANALYSIS BY APPLICATION |
    8. 6.5 US MARKET ANALYSIS BY END USER |
    9. 6.6 KEY BUYING CRITERIA OF MEDICAL DEVICE |
    10. 6.7 RESEARCH PROCESS OF MRFR |
    11. 6.8 DRO ANALYSIS OF MEDICAL DEVICE |
    12. 6.9 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE |
    13. 6.10 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE |
    14. 6.11 SUPPLY / VALUE CHAIN: MEDICAL DEVICE |
    15. 6.12 MEDICAL DEVICE, BY GRAFT TYPE, 2024 (% SHARE) |
    16. 6.13 MEDICAL DEVICE, BY GRAFT TYPE, 2024 TO 2035 (USD Million) |
    17. 6.14 MEDICAL DEVICE, BY PRODUCT TYPE, 2024 (% SHARE) |
    18. 6.15 MEDICAL DEVICE, BY PRODUCT TYPE, 2024 TO 2035 (USD Million) |
    19. 6.16 MEDICAL DEVICE, BY APPLICATION, 2024 (% SHARE) |
    20. 6.17 MEDICAL DEVICE, BY APPLICATION, 2024 TO 2035 (USD Million) |
    21. 6.18 MEDICAL DEVICE, BY END USER, 2024 (% SHARE) |
    22. 6.19 MEDICAL DEVICE, BY END USER, 2024 TO 2035 (USD Million) |
    23. 6.20 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
    24. 7.1 LIST OF ASSUMPTIONS | |
      1. 7.1.1 |
    25. 7.2 US MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.2.1 BY GRAFT TYPE, 2025-2035 (USD Million) | |
      2. 7.2.2 BY PRODUCT TYPE, 2025-2035 (USD Million) | |
      3. 7.2.3 BY APPLICATION, 2025-2035 (USD Million) | |
      4. 7.2.4 BY END USER, 2025-2035 (USD Million) |
    26. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
      1. 7.3.1 |
    27. 7.4 ACQUISITION/PARTNERSHIP | |

US US Skin Graft Market Segmentation

US Skin Graft Market By Graft Type (USD Million, 2025-2035)

  • Autograft
  • Allograft
  • Xenograft

US Skin Graft Market By Product Type (USD Million, 2025-2035)

  • Dermatome
  • Powered Dermatome
  • Drum and Knife Dermatome
  • Wound Debridement Devices
  • Others

US Skin Graft Market By Application (USD Million, 2025-2035)

  • Pressure & Venous Ulcers
  • Diabetic Foot Ulcers
  • Burns
  • Surgical Wounds
  • Others

US Skin Graft Market By End User (USD Million, 2025-2035)

  • Hospitals
  • Ambulatory Surgery Centers
  • Specialty Centers

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.